Response to Lehrer and Rheinstein

J Natl Cancer Inst. 2022 Oct 6;114(10):1427-1428. doi: 10.1093/jnci/djac083.

Karen M Tuesley^{1

2}, Penelope M Webb^{1

2}, Melinda M Protani¹, Katrina Spilsbury³, Sallie-Anne Pearson⁴, Michael D Coory⁵, Peter Donovan^{6

7}, Christopher Steer^{8

9}, Louise M Stewart¹⁰, Nirmala Pandeya^{1

2}, Susan J Jordan^{1

2}

¹ School of Public Health, Faculty of Medicine, University of Queensland, Brisbane, Australia.
² Population Health Department, QIMR Berghofer Medical Research Institute, Brisbane, Australia.
³ Institute for Health Research, The University of Notre Dame Australia, Fremantle, Australia.
⁴ Centre for Big Data Research in Health, University of New South Wales, Sydney, Australia.
⁵ Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, Australia.
⁶ Clinical Pharmacology Department, Royal Brisbane and Women's Hospital, Brisbane, Australia.
⁷ Faculty of Medicine, University of Queensland, Brisbane, Australia.
⁸ Border Medical Oncology, Albury-Wodonga Regional Cancer Centre, Albury, Australia.
⁹ University of NSW Rural Clinical School, Albury Campus, Albury, New South Wales, Australia.
¹⁰ School of Population and Global Health, The University of Western Australia, Perth, Australia.

No abstract available

Publication types